Background:
MicroRNA modulation therapy has shown great promise to treat hepatocellular
carcinoma (HCC), however Efficient tissue-specific and safe delivery remains a major challenge.
Objective:
We sought to develop an inorganic-organic hybrid vehicle for the systemic delivery of the
tumor suppressor miR-34a, and to investigate the efficiency of the delivered miR-34a in the treatment
of HCC in vitro and in vivo.
Methods:
In the present study, pEGP-miR cloning and expression vector, expressing miR-34a, was
electrostatically bound to polyethyleneimine (PEI), and then loaded onto ZSM-5 zeolite nanoparticles
(ZNP). Qualitative and quantitative assessment of the transfection efficiency of miR-34a construct in
HepG2 cells was applied by GFP screening and qRT-PCR, respectively. The expression of miR-34a
target genes was investigated by qRT-PCR in vitro and in vivo.
Results:
ZNP/PEI/miR-34a nano-formulation could efficiently deliver into HepG2 cells with low cytotoxicity,
indicating good biocompatibility of generated nanozeolite. Furthermore, five injected doses
of ZNP/PEI/miR-34a nano-formulation in HCC induced male Balb-c mice, significantly inhibited tumor
growth, and demonstrated improved cell structure, in addition to a significant decrease in alphafetoprotein
level and liver enzymes activities, as compared to the positive control group. Moreover,
injected ZNP/PEI/miR-34a nano-formulation led to a noticeable decrease in the CD44 and c-Myc levels.
Results also showed that ZNP/PEI/miR-34a nano-formulation inhibited several target oncogenes
including AEG-1, and SOX-9, in vitro and in vivo.
Conclusion:
Our results suggested that miR-34a is a powerful candidate in HCC treatment and that
AEG-1 and SOX-9 are novel oncotargets of miR-34a in HCC. Results also demonstrated that our
nano-formulation may serve as a candidate approach for miR-34a restoration for HCC therapy, and
generally for safe gene delivery.
Breast cancer is the most common cancer among women in Malaysia. Therefore, it is highly important for the public to be educated on breast cancer and to know the steps to detect it early on. Healthcare providers are in the prime position to provide such education to the public due to their high knowledge regarding health and their roles in healthcare. The present systematic review involved studies conducted in recent years to analyze the knowledge, attitudes and behavior of Malaysian healthcare providers regarding breast cancer, in attempts to obtain an overall picture of how well equipped our healthcare providers are to provide optimal breast cancer education, and to see their perceptions and actual involvement in said education. The systematic review was conducted via a primary search of various databases and journal websites, and a secondary search of references used by eligible studies. Criteria for eligibility included being published from the year 2008 till present, being conducted in Malaysia, and being written in the English language. A total of two studies were eligible for this review. Findings show that Malaysian future and current healthcare providers have moderate knowledge on breast cancer, have a positive towards involvement of breast cancer education, but have poor actual involvement.
BACKGROUNDActivated leukocyte cell adhesion molecules (ALCAMs) play an essential role in tumor metastasis and are higher in some patients with breast cancer.AIMThis study aimed to evaluate ALCAM as an early diagnostic biomarker for breast cancer and how it compares with other markers.SUBJECTS AND METHODSOne-hundred and sixty-one women were selected for this study. They were divided into three groups: Group 1 consisted of 42 healthy individuals (control) while a patients groups divided into two groups according to tumour grade, Group II, Include 58 breast cancer patient’s grade II and Group III, Include 61 patients with grade III of breast cancer. Tumour markers CEA, CA 15-3 and s ALCAM levels were determined and Group 2 consisted of breast cancer patients.RESULTSA highly significant elevation was recorded in s ALCAM, CA 15-3 and CEA. Percent change for grade II and grade III were [sALCAM (90, 127)], [CA15-3 (40, 72)] and [CEA (33, 156)]. Operating characteristic (ROC) curves were used to evaluate the diagnostic performance of the biomarkers ALCAM, CA15-3 and CEA with area under the curve (AUC) of (0.99 & 1.0) (AUC 0.947 & 0.99) and (AUC 0.88 & 0.94) for grade II and grade III respectively the incremental values of AUC were statistically highly significant (p < 0.001).CONCLUSIONIt could be concluded that serum ALCAM concentration represents a suitable biomarker for Saudi arabian breast carcinoma with high sensitivity and has the potential to be used as a diagnostic tool comparable to CA15-3 and CEA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.